Shandong Weigao Group increases treasury holdings with new share repurchase

Shandong Weigao Group Medical Polymer Company Limited, a listed issuer, disclosed a share repurchase on December 5, 2025. The company bought back 100,000 ordinary shares at a volume-weighted average price of HK$5.484 per share, with the highest price paid being HK$5.49 and the lowest HK$5.48. The total aggregate price paid for these repurchased shares amounted to HK$548,400.

This transaction decreased the number of issued shares (excluding treasury shares) by 100,000, representing 0.0022% of the existing number of issued shares before the event. Conversely, the number of treasury shares increased by 100,000, bringing the total treasury shares to 27,709,200. The total number of issued shares remains at 4,522,332,324.

The repurchase was made under a mandate granted on May 27, 2025, which authorized the company to repurchase a total of 451,560,392 shares. As of December 5, 2025, the company has repurchased 21,060,800 shares under this mandate, representing 4.664% of the issued shares (excluding treasury shares) at the time the mandate was granted. A moratorium period for any new share issues or transfers of treasury shares is in effect until January 4, 2026.